|
|||||
|
|
Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms |
|
| Authors: | Marcel O. Bonn-Miller Megan L. Oser Meggan M. Bucossi Jodie A. Trafton |
| Affiliation: | 1. National Center for PTSD, VA Palo Alto Health Care System, 795 Willow Road (152-MPD), Menlo Park, CA, 94025, USA 2. Center for Health Care Evaluation, VA Palo Alto Health Care System, 795 Willow Road (152-MPD), Menlo Park, CA, 94025, USA 3. Center of Excellence in Substance Abuse Treatment and Education, Philadelphia VAMC, 3900 Woodland Ave., Philadelphia, PA, 19104, USA 4. Department of Psychiatry, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA 5. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA |
| Abstract: | Occasional cannabis use has been associated with increased antiretroviral therapy (ART) adherence and relief of HIV symptoms, while heavy use has been associated with low ART adherence and negative psychological symptoms. The purpose of the present study was to investigate differences between non-cannabis use (NC), non-dependent cannabis use (C), and dependent use (CD) in terms of ART adherence and HIV symptoms/ART side effects. A cross-sectional sample of 180 HIV+ individuals (78.3 % male) completed measures of substance use and psychopathology, medication adherence, and HIV symptoms/ART side effects. Adherence was also measured via pill count, viral load, and CD4 count. Results indicated that the CD group reported lower adherence and greater HIV symptoms/ART side effects than the other two groups, with no differences observed between NC and C groups. There is a clinical need to address dependent cannabis use among those prescribed ART. Further examination is needed to ascertain the functions of cannabis use among individuals with HIV. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |